Corporate Team

Dr.Tony Milici

Chairman and CEO

Dr. Milici founded GeneThera in 1998 and has served as its Chairman and CEO since inception. Dr. Milici was a Research Assistant Professor in the Department of Molecular Pathology at the University of Texas M.D. Anderson Cancer Centre. Assistant Professor at the University of Georgia Medical School and Adjunct Associate Professor at AMC Cancer Centre Colorado Health Science University. He was awarded/earned a Ph.D. (Experimental Haematology) University of Rome and Post-Doctoral Degrees from Stanford University, and University of Texas; and M.D. (Medicine and Surgery) degree from the University of Rome, Rome, Italy; Dr. Milici’s specialties include Molecular Biology, Biotechnology, Molecular Medicine, Gene Therapy, Molecular Oncology, and Molecular Robotics.

Tannya L. Irizarry

Chief Administrative Officer

Chief Administrative Officer of GeneThera since 1999. Currently, she is acting as Chief Financial Officer. Ms. Irizarry has over eighteen years of experience in the medical and biotechnology industries. Ms. Irizarry worked at the University of Texas M.D. Anderson Cancer Center in the Neuro-Oncology Department and Office of Education; and at St. Joseph Hospital in the biotechnology division. Ms. Irizarry served as Vice President for Genetrans, Inc. from 1994 until 1998

Dr. Stefan Milici

Robotic Bioengineer

Robotic Bioengineer works in the field of robotics and integration software. He has a Master in Science and Medical Engineering from the University of Rome, Italy and a Ph.D. in Robotics from the Department of Electronics and Automatics at the University of Tarragona, Spain. As a Ph.D. student, he was enrolled in the EMERGENT European Advanced Biomedical Robotics Program.

Dr. Corrado Passeri

Robotic Bioengineer and Artificial Intelligence Software Developer

Dr. Passeri developed complex software systems such as User Interface software to remotely control robotic components. Dr. Passeri holds a Ph.D. in Robotics and AI from the University of Rome, Italy and UCLA.

Corporate Structure :

GeneThera is currently listed on the OTC Markets. In Compliance with SEC Financial Reports under the stock symbol, ‘GTHR’, and is a fully reporting company with the Securities and Exchange Commission.